glp-1 biotech RenBio is excited to provide an update on our ultra long-acting receptor agonist program Future diabetes care seen leaning

(2018) www.sciencedirect.com From the publication: Patient interest in fertility and testicular size preservation and a desire to avoid lifelong medical therapy with testosterone drives the need to identify non-TTh [non-testosterone therapy] for hypogonadism

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: a polysomnographic randomized, double-blind, placebo-controlled study

The majority of clinical studies have been funded or co-funded by the manufacturer, and sample sizes remain modest (typically 20 to 40 subjects)

Oral tranexamic acid lightens refractory melasma

Who should avoid BPC-157